SRI-29132
SRI-29132 is a potent leucine-rich repeat kinase 2 (LRRK2) inhibitor. SRI-29132 is promising for research of Parkinson’s disease[1].
Product Specifications
CAS Number
[1482305-44-1]
UNSPSC
12352005
Target
LRRK2
Related Pathways
Autophagy
Field of Research
Neurological Disease
Smiles
O=C(C(CC)SC1=NN2C(C=C1)=NN=C2C3=CC=CS3)N4CCCCC4
Molecular Formula
C18H21N5OS2
Molecular Weight
387.52
References & Citations
[1]Moukha-Chafiq O, et al. Discovery of a Chiral 2,4-Substituted Pyrrolo[2,3-d]pyrimidine as a Potent, Selective, and Orally Bioavailable LRRK2 Inhibitor. J Med Chem. 2025 May 22;68 (10) :9926-9946.
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-165543/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
